Purple Biotech Ltd (PPBT) — Financial Flexibility Index
Purple Biotech Ltd (PPBT) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of ILA-1.07 Million (operating CF ILA-1.07 Million minus capex ILA0.00) represents 0% of total liabilities (ILA6.25 Million). Check how strategically is Purple Biotech Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Purple Biotech Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Purple Biotech Ltd across 8 annual periods. See Purple Biotech Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Purple Biotech Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Purple Biotech Ltd. For the full company profile including market capitalisation, see Purple Biotech Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.48x | ILA-14.37 Million | ILA-14.37 Million | ILA4.13 Million | ▼ -74.8% |
| 2023 | -1.99x | ILA-19.92 Million | ILA-19.93 Million | ILA10.01 Million | ▲ +10.3% |
| 2022 | -2.22x | ILA-16.71 Million | ILA-16.73 Million | ILA7.52 Million | ▲ +25.3% |
| 2021 | -2.97x | ILA-15.14 Million | ILA-15.25 Million | ILA5.09 Million | ▼ -0.9% |
| 2020 | -2.95x | ILA-11.94 Million | ILA-12.09 Million | ILA4.05 Million | ▼ -104.1% |
| 2019 | -1.44x | ILA-5.57 Million | ILA-5.58 Million | ILA3.86 Million | ▲ +36.6% |
| 2018 | -2.28x | ILA-8.46 Million | ILA-8.48 Million | ILA3.72 Million | ▼ -47.7% |
| 2017 | -1.54x | ILA-8.61 Million | ILA-8.63 Million | ILA5.59 Million | — |